Skip to main content
Cyber Week Sale - Get 40% off Vantage
Get Started
SubscribeLogin
Published • loading... • Updated

Canada’s Public Health Plans End Talks with Novo Nordisk to Cover Weight-Loss Drug Wegovy

Summary by The Globe & Mail
Drug contains same active ingredient as Ozempic, which is prescribed for type 2 diabetes and is by far the best-selling drug in Canada

1 Articles

The Globe & MailThe Globe & Mail
Center

Canada’s public health plans end talks with Novo Nordisk to cover weight-loss drug Wegovy

Drug contains same active ingredient as Ozempic, which is prescribed for type 2 diabetes and is by far the best-selling drug in Canada

·Canada
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

The Globe & Mail broke the news in Canada on Monday, December 1, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Ozempic icon

Ozempic

Wegovy icon

Wegovy

Canada icon

Canada

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal